DSI Aloha Dialysis Center is a medicare approved dialysis facility center in Honolulu, Hawaii and it has 20 dialysis stations. It is located in Honolulu county at 1520 Liliha Street, Suite 101, Honolulu, HI, 96817. You can reach out to the office of DSI Aloha Dialysis Center at (808) 531-1748. This dialysis clinic is managed and/or owned by Diversified Specialty Institutes (dsi). DSI Aloha Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 1988. The medicare id for this facility is 122503 and it accepts patients under medicare ESRD program.
| Name | DSI Aloha Dialysis Center |
|---|---|
| Location | 1520 Liliha Street, Suite 101, Honolulu, Hawaii |
| No. of Dialysis Stations | 20 |
| Medicare ID | 122503 |
| Managed By | Diversified Specialty Institutes (dsi) |
| Ownership Type | Profit |
| Late Shifts | No |
| 1520 Liliha Street, Suite 101, Honolulu, Hawaii, 96817 | |
| (808) 531-1748 | |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| NPI Number | 1346516812 |
| Organization Name | U.s. Renal Care Aloha Dialysis |
| Doing Business As | Dialysis Newco Inc |
| Address | 1520 Liliha St Honolulu, Hawaii, 96817 |
| Phone Number | (808) 531-1748 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| NPI Number | 1366804478 |
| Organization Name | U.s. Renal Care Beretania Dialysis |
| Doing Business As | Usrc Beretania, Llc |
| Address | 1908 S Beretania St Honolulu, Hawaii, 96826 |
| Phone Number | (615) 263-4518 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| NPI Number | 1427160225 |
| Organization Name | Fmc Aloha Dialysis Center |
| Doing Business As | Bio-medical Applications Of California, Inc. |
| Address | 1520 Liliha St Honolulu, Hawaii, 96817 |
| Phone Number | (808) 531-1748 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 70% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 11% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 19% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 60% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 14% |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 66% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 15% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 19% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 67% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 20% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 12% |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 77% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 23% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 72% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 10% | 12% |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 53 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 6 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 145 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1297 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at DSI Aloha Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 151 |
| Hypercalcemia patient months | 1354 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 155 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 93 |
| Patient months included in arterial venous fistula and catheter summaries | 686 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 76 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 95 |
| Hospitalization Rate in facility | 171.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 285.8 |
| Hospitalization Rate: Lower Confidence Limit | 105.3 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at DSI Aloha Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.1 |
| Readmission Rate: Lower Confidence Limit | 13.6 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at DSI Aloha Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .58 (As Expected) |
| SIR: Upper Confidence Limit | 1.4 |
| SIR: Lower Confidence Limit | .19 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether DSI Aloha Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 89 |
| Transfusion Rate in facility | 47.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 99.8 |
| Transfusion Rate: Lower Confidence Limit | 25 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at DSI Aloha Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 546 |
| Mortality Rate in facility | 15.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.9 |
| Mortality Rate: Lower Confidence Limit | 11.6 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago
DSI Honolulu Dialysis Center Location: 226 N. Kuakini St, Honolulu, Hawaii, 96817 Phone: (808) 545-3933 |
DSI Aloha Dialysis Center Location: 1520 Liliha Street, Suite 101, Honolulu, Hawaii, 96817 Phone: (808) 531-1748 |
Siemsen Dialysis Facility Location: 2226 Liliha Street Suite 226, Honolulu, Hawaii, 96817 Phone: (808) 585-4660 |
DSI Kapahulu Dialysis Center Location: 750 Palani Avenue, Honolulu, Hawaii, 96816 Phone: (808) 732-7702 |
News Archive
Warning labels on sugar-sweetened beverages (SSB) and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School at Washington University in St. Louis.
Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is launching two new hands-on training systems - the Lap Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will be revealed for the first time at the AUA annual meeting in San Francisco next week.
› Verified 9 days ago